o_19ntugujs11ikbdrctt1teabbla.pdf
MRRSE.Com announces addition of new report"Ovarian Cancer Therapeutics Market the World Cancer Research Market-Analysis, Size, Share, Growth, Trends and Forecast2015-2020"to its database
MRRSE.Com announces addition of new report"Ovarian Cancer Therapeutics Market the World Cancer Research Market-Analysis, Size, Share, Growth, Trends and Forecast2015-2020"to its database
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
6.1.2 PharmaMar Enters into Licensing Agreement with Janssen for Yondelis<br />
6.1.3 Hana Enters into Licensing Agreement with Tekmira<br />
6.1.4 AstraZeneca Enters into Licensing Agreement with Merck for MK-1775<br />
6.1.5 Tesaro Enters into Licensing Agreement with Merck Sharp & Dohme for Cancer Drug<br />
6.1.6 Oasmia Enters into Licensing Agreement with Medison for Paclical<br />
6.1.7 Orion Enters into Agreement with Oasmia<br />
6.1.8 Ohio University Enters into Licensing Agreement with Phosplatin<br />
6.1.9 Genta Enters into Licensing Agreement with Daiichi Sankyo<br />
6.1.10 Celldex Enters into Licensing Agreement with the Ludwig Institute for Cancer Research<br />
6.1.11 NanoCarrier Enters into Licensing Agreement with Kowa for NC-6300<br />
6.2 Co-development Deals<br />
6.2.1 Bristol-Myers Squibb Enters into Co-development Agreement with Ono Pharma<br />
6.2.2 Merck Enters into Co-development Agreement with Endocyte for Cancer Drug<br />
6.2.3 Pfizer Enters into Research Agreement with BC Cancer Agency and Vancouver Prostate<br />
Centre<br />
6.2.4 Almac Discovery Enters into an Agreement with Queen’s University Belfast for Drug<br />
Discovery<br />
7 Appendix<br />
7.1 All Pipeline Drugs by Phase<br />
7.1.1 Discovery<br />
7.1.2 Preclinical<br />
7.1.3 IND/CTA-Filed<br />
7.1.4 Phase I<br />
7.1.5 Phase II
Change language